Blogs about: Jak2
Featured Blog
Cytopia to present JAK2 data at conferences
Cytopia Limited are to present data on its JAK2 inhibitor program at two important scientific meetings this month – the Hematological Society of Australia and New Zealand and the ‘Drug Dis… more →
Kinase News
Cytopia to present JAK2 data at conferences
crimsoncanary wrote 1 year ago: Cytopia Limited are to present data on its JAK2 inhibitor program at two important scientific meetin … more →
Supergen to present on Kinase drugs at EORTC-NCI-AACR
crimsoncanary wrote 1 year ago: SuperGen are to present data on the following kinase inhibitors at the 20th EORTC-NCI-AACR Symposium … more →
Incytes JAK2 inhibitor INCB18424 demonstrates POC in Psoriasis
crimsoncanary wrote 1 year ago: Incyte have reported positive results from Phase IIa clinical trials of JAK2 inhibitor INCB18424 in … more →
S*BIO Initiate Phase I trial of JAK2 Inhibitor SB1518
crimsoncanary wrote 1 year ago: S*BIO Pte have announced the initiation of multi-center Phase I clinical trials of JAK2 inhibitor SB … more →
AstraZenecas JAK2 inhibitor AZ960 active in vitro
crimsoncanary wrote 1 year ago: AstraZenecas AZ960 inhibits JAK2 with a Ki of 0.00045 µM in vitro and demostrates apoptic activity i … more →
S*Bio initate Phase I/II trial of JAK2 inhibitor SB1518 in Chronic Idiopathic Myelofibrosis
crimsoncanary wrote 1 year ago: S*Bio have initated a Phase I/II trial of JAK2 inhibitor SB1518 in Chronic Idiopathic Myelofibrosis … more →
Cytopia to present on JAK2 program at ACS meeting
crimsoncanary wrote 1 year ago: Cytopia have announced that it will be presenting data on its JAK2 program at the Philadelphia ACS m … more →
Incyte report on INCB18424 and INCB28050 progress
crimsoncanary wrote 1 year ago: In 2nd quarter results Incyte have provided an update on JAK2 inhibitors INC18424 and INCB28050 … more →
Cytopia gearing up for JAK2 clinical trial
crimsoncanary wrote 1 year ago: Cytopia have appointed a Study chair at the Mayo Clinic in preparation of Phase I JAK2 trials for my … more →
SuperGens JAK2 inhibitor SGI-1252 inhibits tumor cell proliferation in vivo
crimsoncanary wrote 1 year ago: Data presented at the European Hematology Association show SuperGen’s JAK2 inhibitor SGI-1252 … more →
Incytes INCB-18424 shows efficacy in RA
crimsoncanary wrote 1 year ago: Phase I data presented at EULAR show Incytes JAK 1/2 inhibitor INCB018424 to demonstrate efficacy in … more →
Inhibition of FXR suppresses STAT3 via Jak2 and c-Src
crimsoncanary wrote 1 year ago: Researchers at the University of Texas have determined that FXR inhibition (in this study with guggu … more →
Incyte's JAK inhibitor INCB18424 shows efficacy in treating Myelofibrosis symptoms
crimsoncanary wrote 1 year ago: Phase I/II data presented at ASCO show Incyte’s JAK inhibitor INCB18424 reduced fatigue, night … more →
Aegera's JAK2 inhibitor LS-104 induces ap
crimsoncanary wrote 1 year ago: LS104 inhibited JAK2 kinase activity in vitro and strongly inhibited cytokine-independent growth of … more →
SGX gives Pipeline update
crimsoncanary wrote 1 year ago: SGX126 – Met inhibitor – IND-enabling studies continuing, IND expected early 2009 SGX523 … more →
Incyte highlight progress of INCB18424, JAK Inhibitor
crimsoncanary wrote 1 year ago: Incyte updates with progress of JAK inhibitor INCB18424 during first quarter conference call: Myelof … more →
